What is Global Gastric Electric Stimulation (GES) Devices Market?
The Global Gastric Electric Stimulation (GES) Devices Market is a rapidly evolving sector that focuses on the production and distribution of devices designed to stimulate the stomach's electrical activity. These devices are primarily used to treat gastroparesis, a condition characterized by delayed gastric emptying in the absence of mechanical obstruction. The GES devices work by sending mild electrical pulses to the nerves and smooth muscles of the lower stomach, which helps control nausea and vomiting, symptoms often associated with gastroparesis. The global market for these devices is driven by factors such as the increasing prevalence of gastroparesis, technological advancements in GES devices, and growing awareness about the benefits of these devices among healthcare professionals and patients. The market is also influenced by regulatory policies, reimbursement scenarios, and the economic environment in different regions.
Low Frequency GES Device, High Frequency GES Device in the Global Gastric Electric Stimulation (GES) Devices Market:
The Global Gastric Electric Stimulation (GES) Devices Market is segmented into Low Frequency GES Devices and High Frequency GES Devices. Low Frequency GES Devices operate at a frequency of 3 cycles per minute, mimicking the stomach's natural electrical rhythm. These devices are designed to stimulate gastric contractions, promoting gastric emptying and alleviating symptoms of gastroparesis. On the other hand, High Frequency GES Devices operate at a frequency of 12 cycles per minute. These devices do not stimulate gastric contractions; instead, they modulate the activity of the enteric nervous system, reducing symptoms of nausea and vomiting. Both types of devices have their advantages and are chosen based on the patient's specific needs and the physician's discretion. The market for these devices is influenced by factors such as technological advancements, clinical trial outcomes, and patient and physician preferences.
Hospitals, Clinics, Other in the Global Gastric Electric Stimulation (GES) Devices Market:
The Global Gastric Electric Stimulation (GES) Devices Market finds its applications in various healthcare settings such as Hospitals, Clinics, and Others. In hospitals, these devices are used in the treatment of patients with severe gastroparesis who do not respond to conventional therapies. The devices are implanted through a minimally invasive surgical procedure, which can be performed in a hospital setting. Clinics also use these devices for the management of gastroparesis symptoms in outpatients. Other settings where these devices are used include research institutions for conducting clinical trials and studies on the efficacy and safety of GES therapy. The choice of setting depends on factors such as the severity of the patient's condition, the availability of skilled healthcare professionals, and the patient's preference.
Global Gastric Electric Stimulation (GES) Devices Market Outlook:
The future of the Global Gastric Electric Stimulation (GES) Devices Market looks promising, with a steady growth trajectory projected for the coming years. In 2023, the market was valued at US$ 227 million. This value is expected to increase significantly, reaching an estimated US$ 347.7 million by 2030. This represents a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing prevalence of gastroparesis, advancements in GES technology, and growing awareness about the benefits of GES therapy among healthcare professionals and patients. However, the market's growth may be influenced by factors such as regulatory policies, reimbursement scenarios, and the economic environment in different regions.
| Report Metric | Details |
| Report Name | Gastric Electric Stimulation (GES) Devices Market |
| Accounted market size in 2023 | US$ 227 million |
| Forecasted market size in 2030 | US$ 347.7 million |
| CAGR | 6.3% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Medtronic, IntraPace, ReShape Lifesciences |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
